Columvi
Drug timelines are a Plus or Pro feature.
25 regulatory and trial events tracked for Columvi, covering 2023-06-15 to 2026-04-08. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma [Phase 3]